HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomised double-blind trial of the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis.

AbstractBACKGROUND:
Chlamydia trachomatis is the most common bacterial cause of cervicitis.
AIM:
The aim of this randomised, double-blind trial was to compare the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis.
METHODS:
Eighty women with increased anti-C. trachomatis IgM, reporting abnormal vaginal discharge and dyspareunia, demonstrating signs of cervical oedema and erythema and friability of cervix were included. Thirty-nine women received doxycycline capsules 100 mg twice daily plus triple sulfa vaginal cream once daily for ten days, and 41 received doxycycline capsules 100 mg twice-daily and triple sulfa vaginal cream once daily plus vitamin C tablets 250 mg once daily for ten days. Women were evaluated at follow-up visit, eleventh day, following completion of intervention.
ANALYSIS:
The effect of treatment was assessed regarding clinical criteria (presence of endocervical mucopus and cervical severity score) and presence of dyspareunia. Statistical analysis was carried out using spss version 11.5.
RESULTS:
The mean age of women was 30.6 +/- 8.4 years. There was no relationship between demographics and dyspareunia and discharge (P > 0.05). There was statistically significant difference between the effect of 'doxycycline plus triple sulfa' and 'doxycycline, triple sulfa plus vitamin C' on discharge and dyspareunia (P = 0.005, P < 0.001, respectively). Most frequently reported drug-related adverse event in both groups was heartburn.
CONCLUSION:
Adding vitamin C to doxycycline and triple sulfa was more efficient than standard regimen (doxycycline and triple sulfa without vitamin C) in treating chlamydial cervicitis.
AuthorsMarjan Khajehei, Tahereh Keshavarz, Hamid Reza Tabatabaee
JournalThe Australian & New Zealand journal of obstetrics & gynaecology (Aust N Z J Obstet Gynaecol) Vol. 49 Issue 5 Pg. 525-30 (Oct 2009) ISSN: 1479-828X [Electronic] Australia
PMID19780738 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Antioxidants
  • Drug Combinations
  • Vaginal Creams, Foams, and Jellies
  • Sulfadiazine
  • Sulfamethazine
  • trisulfapyrimidine
  • Doxycycline
  • Ascorbic Acid
  • Sulfamerazine
Topics
  • Administration, Oral
  • Adult
  • Anti-Bacterial Agents
  • Antioxidants (therapeutic use)
  • Ascorbic Acid (therapeutic use)
  • Chlamydia Infections (complications, drug therapy)
  • Double-Blind Method
  • Doxycycline (administration & dosage)
  • Drug Combinations
  • Drug Therapy, Combination
  • Dyspareunia (drug therapy, microbiology)
  • Female
  • Humans
  • Sulfadiazine (administration & dosage)
  • Sulfamerazine (administration & dosage)
  • Sulfamethazine (administration & dosage)
  • Uterine Cervicitis (complications, drug therapy, microbiology)
  • Vaginal Creams, Foams, and Jellies
  • Vaginal Discharge (drug therapy, microbiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: